Brief: Iconovo Gets Order From ISR Regarding Nasal COVID-19 Vaccine

Iconovo AB

12/07/2021 08:08

July 12 (Reuters) - Iconovo AB  ICO.ST :
    * ICONOVO RECEIVES AN ORDER FOR ADDITIONAL WORK FROM ISR FOR DEVELOPMENT OF A NASAL COVID-19
VACCINE
    * ADDITIONAL ORDER MAY GIVE ICONOVO UP TO 4.9 MSEK IN ADDITION TO PREVIOUSLY ANNOUNCED
AGREEMENT.
    * GETS ORDER FROM ISR IMMUNE SYSTEM REGULATION AB, A SUBSIDIARY OF ISR IMMUNE SYSTEM
REGULATION
HOLDING AB, FOR ADDITIONAL WORK FOR ONGOING PROJECT WITH INHALED COVID-19 VACCINE WITH A
DEVELOPMENT OF A NASAL VERSION OF ICONOVO'S INHALER ICOONE
    * ADDITIONAL ORDER MAY GIVE CO UP TO 4.9 MSEK IN ADDITION TO PREVIOUSLY ANNOUNCED AGREEMENT
    * TOTAL VALUE OF ORDER IS 10.4 MSEK, WHICH IS 4.9 MSEK IN ADDITION TO PREVIOUSLY
COMMUNICATED
CONTRACTUAL SUMS

Source text for Eikon:  ID:nMFN2MjDfD 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))